Antibodies for Cancer Research

Cancer Research Antibodies

At Atlas Antibodies we have a strong focus on cancer and offer a wide selection of PrecisA Monoclonals™ and Triple A Polyclonals™ for cancer research.

Triple A Polyclonals for cancer research

Triple A Polyclonals are rabbit polyclonal antibodies developed within the Human Protein Atlas project. We offer 21,000 Triple A Polyclonals, each supplied with more than 500 annotated IHC images including images from cancerous tissues. The antibodies have been used for staining of 48 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type.

See all Triple A Polyclonals

Cancer Stem Cell Markers

Cancer stem cells (CSCs) are a small number of cells that drive the tumor’s initiation, growth and metastasis, and may cause relapse. Due to their importance, several biomarkers that characterize CSCs have been identified, allowing diagnostic, therapeutic, and prognostic predictions. Atlas Antibodies offer antibodies targeting several proteins relevant as CSC markers, focusing on solid and hematological cancers.

Explore CSC markers

Cancer Stem Cell Markers

Mechanisms in Cancer

Cell Cycle Markers

Cell Death Markers

Metastasis Markers

Tumor Angiogenesis and Lymphoangiogenesis Markers

Tumor Proliferation Markers

ATRX and Glioma Markers

Glioma is a common type of brain tumor, that springs from glial cells. The tumor type comprises about 80% of all malignant brain tumors and often carry a very poor prognosis. Atlas Antibodies offer antibodies targeting several proteins relevant for glioma characterization, including ATRX, IDH1, and GFAP.

Explore glioma markers

ATRX and Glioma Markers

Oncology Biomarkers

Atlas Antibodies recognize the need for new biomarkers to provide a more accurate diagnosis and a better assessment of patient prognosis, ultimately leading to a more individualized treatment. Together with our research partners in the Human Protein Atlas project we are in a unique position to perform antibody-based biomarker discovery. Learn about our oncology biomarkers T-PIT / TBX19, SATB2, PODXL and  RBM3.  

Explore oncology biomarkers

Oncology Biomarkers

EMT Markers

The Epithelial-to-Mesenchymal Transition (EMT) is a process that normally occurs during embryogenesis, but is also present in wound healing and cancer progression of epithelial tumors. Our EMT marker antibody panel includes mouse monoclonals targeting key EMT markers for cell junctions, cytoskeletal changes, transcription regulation and migration/motility.

Explore EMT markers

EMT Markers

Colorectal Cancer

A large number of our antibodies are relevant for scientists studying colorectal cancer. In this brochure, we catalog our antibodies related to the field of colorectal cancer research together with publication references.

Explore our colorectal cancer catalog

Colorectal Cancer

Breast Cancer

A wide range of our antibodies is used by scientists working to understand breast cancer.  In this brochure, we catalog our antibodies related to the field of breast cancer research together with publication references. 

Explore our breast cancer catalog

Breast Cancer

Pathology Atlas

The Pathology Atlas section of the Human Protein Atlas provides information on the role of genes, RNA, proteins, and metabolites in the human cancerous tissues and organs. It is a valuable resource helping researchers and pathologists to improve testing methods to predict and find new treatments for fighting cancer.

Learn about the Pathology Atlas

Browse primary antibodies

Find the antibody you need in our product catalog. 

Browse products